Macquarie Group
BNGO icon

Macquarie Group’s Bionano Genomics BNGO Stock Holding History

Macquarie Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-46
Closed -$60K – 1798
2022
Q3 		$60K Sell
46
-8
-15% -$10.6K ﹤0.01% 1906
2022
Q2 		$45K Hold
54
– – ﹤0.01% 2074
2022
Q1 		$84 Buy
54
+46
+575% +$62.1K ﹤0.01% 2004
2021
Q4 		$15K Hold
8
– – ﹤0.01% 2457
2021
Q3 		$28K Hold
8
– – ﹤0.01% 2379
2021
Q2 		$37K Buy
+8
New +$31.6K ﹤0.01% 2226

Other funds holding BNGO

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Macquarie Group's BNGO Position: Q4 2022 in Review

Macquarie Group sold out of Bionano Genomics (BNGO) in Q4 2022, closing a stake of 46 shares — an estimated $60K sold.

Macquarie Group first reported a position in BNGO in Q2 2021 and held it in 6 quarters. The position peaked at $60K in Q3 2022. 143 funds tracked by Wall St. Rank hold BNGO as of Q4 2022.

  • Macquarie Group reported no remaining Bionano Genomics position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 46 Bionano Genomics shares in Q4 2022, an estimated $60K.
  • Macquarie Group first reported a position in Bionano Genomics in Q2 2021 and held it in 6 quarters.
  • Macquarie Group's Bionano Genomics position peaked at $60K in Q3 2022.
  • 143 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.